Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

The present research was aimed at finding informative criteria for regulating the procedure to determine the interchangeability of systemic levofloxacin-based medicinal products (MP) registered in the RF. The chemical and pharmaceutical characteristics of excipients in 26 commercial levofloxacin products (film-coated tablets for internal use) were compared. Their product lines and instructions for medicinal use were also analyzed. It was shown that the compositions of levofloxacin tablets offered on the RF market differed significantly. It was established that the elaboration and implementation of informative criteria for regulating the procedure to determine the interchangeability of levofloxacin-based drugs should benefit the evaluation of drug quality during the determination of the interchangeability for medicinal use.

Об авторах

V. Kocherovets

Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 119991; Moscow, 127051

N. Bunyatyan

Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 119991; Moscow, 127051

Yu. Olefir

Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 119991; Moscow, 127051

R. Alyautdin

Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

B. Romanov

Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

A. Prokof’ev

Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 119991; Moscow, 127051

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media New York, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).